Cases & Deals

Share

Baxter Ventures invests in VitalConnect

May 2017

Client(s) Baxter Ventures

Jones Day represented Baxter Ventures in connection with its purchase of Series C Preferred Stock in a private placement by VitalConnect, a leader in medical-grade wearable biosensor systems. MVM Life Science Partners LLP acted as a co-investor.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.